Login / Signup

Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).

Hideto KamedaKohei HagimoriYoji MorisakiThorsten HolzkämperAyako KonomiHiroaki Dobashi
Published in: Rheumatology and therapy (2024)
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • early onset
  • study protocol
  • chemotherapy induced
  • randomized controlled trial
  • open label